Fatima Z - Search Results

1

Implications and Economic Impact of Applying International Guidelines and Recommendations to the Management of High-Risk Group of Type 2 Diabetes Mellitus Patients in India.

Fatima Z, Atal S, Joshi R, Sadasivam B. Fatima Z, et al. Cureus. 2022 Feb 11;14(2):e22141. doi: 10.7759/cureus.22141. eCollection 2022 Feb. Cureus. 2022. PMID: 35308676 Free PMC article.

2

Pattern of Disease and Therapy for Diabetes along with Impact of Generic Prescribing on Cost of Treatment among Outpatients at a Tertiary Care Facility.

Atal S, Joshi R, Balakrishnan S, Singh P, Fatima Z, Jain N. Atal S, et al. Among authors: fatima z. J Pharm Bioallied Sci. 2021 Jan-Mar;13(1):93-101. doi: 10.4103/jpbs.JPBS_405_20. Epub 2020 Dec 16. J Pharm Bioallied Sci. 2021. PMID: 34084054 Free PMC article.

3

Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus.

Atal S, Fatima Z, Singh S, Balakrishnan S, Joshi R. Atal S, et al. Among authors: fatima z. Diabetol Int. 2020 Oct 29;12(3):247-253. doi: 10.1007/s13340-020-00472-4. eCollection 2021 Jul. Diabetol Int. 2020. PMID: 34150432 Free PMC article. Review.

4

Patterns of drug therapy, glycemic control, and predictors of escalation - non-escalation of treatment among diabetes outpatients at a tertiary care center.

Atal S, Joshi R, Misra S, Fatima Z, Sharma S, Balakrishnan S, Singh P. Atal S, et al. Among authors: fatima z. J Basic Clin Physiol Pharmacol. 2021 Aug 27;33(6):803-814. doi: 10.1515/jbcpp-2021-0189. eCollection 2022 Nov 1. J Basic Clin Physiol Pharmacol. 2021. PMID: 34449177

5

IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?

Atal S, Fatima Z. Atal S, et al. Among authors: fatima z. Pharmaceut Med. 2020 Aug;34(4):223-231. doi: 10.1007/s40290-020-00342-z. Pharmaceut Med. 2020. PMID: 32535732 Free PMC article.

6

Diabetes care during COVID-19 lockdown at a tertiary care centre in India.

Joshi R, Atal S, Fatima Z, Balakrishnan S, Sharma S, Joshi A. Joshi R, et al. Among authors: fatima z. Diabetes Res Clin Pract. 2020 Aug;166:108316. doi: 10.1016/j.diabres.2020.108316. Epub 2020 Jul 14. Diabetes Res Clin Pract. 2020. PMID: 32673697 Free PMC article.

7

Metformin recalls: regulatory background, concerns and challenges.

Sadasivam B, Fatima Z, Atal S. Sadasivam B, et al. Among authors: fatima z. Wien Klin Wochenschr. 2021 Aug;133(15-16):851-854. doi: 10.1007/s00508-021-01822-1. Epub 2021 Feb 23. Wien Klin Wochenschr. 2021. PMID: 33620576 No abstract available.

8

Medication adherence, recall periods and factors affecting it: A community-based assessment on patients with chronic diseases in urban slums.

Atal S, Ray A, Ahmed SN, Singh P, Fatima Z, Sadasivam B, Pakhare A, Joshi A, Joshi R. Atal S, et al. Among authors: fatima z. Int J Clin Pract. 2021 Aug;75(8):e14316. doi: 10.1111/ijcp.14316. Epub 2021 May 20. Int J Clin Pract. 2021. PMID: 34014034

9

Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?

Atal S, Fatima Z, Balakrishnan S. Atal S, et al. Among authors: fatima z. BioDrugs. 2020 Dec;34(6):705-711. doi: 10.1007/s40259-020-00448-5. BioDrugs. 2020. PMID: 33048300 Free PMC article.

10

A Comprehensive Review of Pathophysiological Link Between Non-alcoholic Fatty Liver Disease, Insulin Resistance, and Metabolic Syndrome.

Januario E, Barakat A, Rajsundar A, Fatima Z, Nanda Palienkar V, Bullapur AV, Singh Brar S, Kharel P, Koyappathodi Machingal MM, Backosh A. Januario E, et al. Among authors: fatima z. Cureus. 2024 Dec 13;16(12):e75677. doi: 10.7759/cureus.75677. eCollection 2024 Dec. Cureus. 2024. PMID: 39807459 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters